Arrowhead Research Corp (ARWR) 6.88 $ARWR Seeking

New Post Public Reply Private Reply Replies (0) Message Board

Apr 23, 2015 at 1:36 AM

Arrowhead Research Corp (ARWR) 6.88 $ARWR

Seeking Alpha's Biotech Weekly: Celgene Check-Up, Is Gilead The New Apple?, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Apr 17, 3:00PM CDT
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. This week, contributors geared up for earnings season, highlighted several...
SGYP: 4.01 (-0.06), BIIB: 423.57 (+1.46), ARWR: 6.88 (+0.14), AMGN: 169.10 (+0.64), MYL: 72.40 (-1.67), BMY: 66.60 (-0.21), CNCE: 14.83 (+0.26), CELG: 115.54 (+0.72), ATNM: 3.01 (-0.07), PFS: 18.65 (+0.06), NVIV: 13.76 (-0.19), GILD: 104.18 (-1.02), FWP: 31.77 (-0.66), GWPH: 113.04 (-0.05), IBM: 165.36 (+1.10), BAX: 70.38 (+0.33), AZN: 73.35 (+0.65), TEVA: 63.01 (-1.15)

Where Are The Investors Headed: Complementary Research on Clovis Oncology, DBV Technologies, Cleveland BioLabs, Arrowhead Research and Athenahealth
PR Newswire - Fri Apr 17, 7:25AM CDT
Editor Note: For more information about this release, please scroll to bottom.
DBVT: 25.66 (-0.01), ARWR: 6.88 (+0.14), CLVS: 85.04 (-1.36), CBLI: 3.20 (+0.01), ATHN: 120.16 (-1.35)

Healthcare ratings roundup
Seeking Alpha - at Seeking Alpha - Wed Apr 15, 12:32PM CDT

ICEL: 16.47 (-0.02), ARWR: 6.88 (+0.14), CLVS: 85.04 (-1.36), UNH: 117.81 (-1.47), ABBV: 64.52 (+0.91), NUVA: 43.38 (+0.10)

Buy Arrowhead Research Corporation On The Dip
Clinically Sound Investor - at Seeking Alpha - Wed Apr 15, 6:53AM CDT

ARWR: 6.88 (+0.14)

Nasdaq stocks posting largest percentage decreases
AP - Tue Apr 14, 4:58PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
PFPT: 58.45 (-0.45), ARWR: 6.88 (+0.14), ASPS: 18.07 (+1.32), CTSO: 7.13 (-0.06), SCYX: 7.70 (-0.35), FOMX: 10.94 (-0.02), AKBA: 8.39 (+0.07), TGLS: 11.98 (+0.70), EXA: 11.49 (+0.01), SPKE: 12.97 (+0.09)

Alcatel-Lucent and JPMorgan are big market movers
AP - Tue Apr 14, 3:29PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
NSC: 104.97 (+2.56), ARWR: 6.88 (+0.14), ETH: 25.96 (+0.16), ALU: 4.12 (+0.09), AGI.TO: 8.23 (-0.52), JBLU: 19.67 (-0.16), MGM: 22.03 (+0.32), SHLD: 42.16 (+0.39), FAST: 41.58 (+0.32), JPM: 62.94 (+0.63), QCOM: 68.94 (+0.37), AGI: 6.74 (-0.39), BAS: 7.88 (+0.07), FTK: 15.56 (+0.10), SZYM: 3.71 (-0.06)

Arrowhead Research (ARWR) Stock Falls Today on Jefferies Downgrade
at The Street - Tue Apr 14, 11:51AM CDT
Shares of Arrowhead Research (ARWR) fell Tuesday after Jefferies downgraded the biopharmaceutical company to 'Hold' from 'Buy' and slashed its price target to $9 from $30.
ARWR: 6.88 (+0.14)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Apr 14, 11:45AM CDT

WUBA: 75.56 (+3.20), TANH: 11.82 (+0.40), MTBC: 1.83 (-0.11), ARWR: 6.88 (+0.14), LOJN: 2.57 (+0.04), GNE: 10.19 (+0.29), CBAK: 4.51 (-0.05), HCHC: 11.15 (+0.03), CRDS: 2.58 (-0.02), CHOP: 3.67 (-0.26), NVGN: 7.40 (-0.30), EGY: 2.29 (-0.07), STDY: 10.10 (+0.11), YZC: 10.32 (+0.10), DOVR: 8.42 (-0.02), BRN: 2.51 (unch), BLFS: 2.01 (-0.01), BLDR: 13.00 (-0.09), CCCL: 1.27 (-0.03), SZYM: 3.71 (-0.06)

Arrowhead Research (ARWR) Weak On High Volume
at The Street - Tue Apr 14, 9:19AM CDT
Trade-Ideas LLC identified Arrowhead Research (ARWR) as a weak on high relative volume candidate
ARWR: 6.88 (+0.14)

Critical Alerts For GoDaddy, Disney, Arrowhead Research, Merrimack Pharmaceuticals and Organovo Released By InvestorsObserver
PR Newswire - Tue Apr 14, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for GDDY, DIS, ARWR, MACK and ONVO.
MACK: 13.44 (+0.18), ARWR: 6.88 (+0.14), ONVO: 5.14 (+0.67), DIS: 107.94 (+0.26), GDDY: 24.77 (-0.01)

Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Tue Apr 14, 8:12AM CDT

NSC: 104.97 (+2.56), ARWR: 6.88 (+0.14), GWPH: 113.04 (-0.05), ALU: 4.12 (+0.09), NVGN: 7.40 (-0.30), BLDR: 13.00 (-0.09), BCLI: 4.29 (-0.09), EGY: 2.29 (-0.07), SZYM: 3.71 (-0.06)

Downgrade Alert for Arrowhead Research (ARWR)
Comtex SmarTrend(R) - Tue Apr 14, 8:06AM CDT
Arrowhead Research (NASDAQ:ARWR) was downgraded from Buy to Hold at Jefferies today. The stock closed yesterday at $8.00 on volume of 8.5 million shares, above average daily volume of 1.5 million. Arrowhead Research (NASDAQ:ARWR) has potential upside of 81.3% based on a current price of $8.00 and analysts' consensus price target of $14.50. The stock should find resistance at its 200-day moving average (MA) of $9.24, as well as support at its 50-day MA of $7.23.
ARWR: 6.88 (+0.14)

Arrowhead Research (ARWR) Stock Rises Today as FDA Allows Study to Proceed
at The Street - Mon Apr 13, 10:40AM CDT
Shares of Arrowhead Research (ARWR) were up in late morning trading Monday after the biopharmaceutical company announced a new permission from the Food and Drug Administration.
ARWR: 6.88 (+0.14)

Why Shares of Arrowhead Research Corp. Briefly Spiked Today
George Budwell, The Motley Fool - Motley Fool - Mon Apr 13, 10:03AM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What : Shares of the clinical-stage biotech Arrowhead...
ARWR: 6.88 (+0.14)

BUYINS.NET: ARWR SqueezeTrigger Price is $8.80. There is $138,779,100 That Short Sellers Still Need To Cover.
M2 - Mon Apr 13, 7:58AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring Arrowhead Research Corp (NASDAQ:ARWR) in real time and just received an alert that ARWR is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 15419900 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $8.80. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
ARWR: 6.88 (+0.14)

Arrowhead cleared to proceed to Phase 2b for hep B candidate
Seeking Alpha - at Seeking Alpha - Mon Apr 13, 6:53AM CDT

ARWR: 6.88 (+0.14)

Arrowhead Cleared to Proceed with Multiple Dose Phase 2b Study of ARC-520
Business Wire - Mon Apr 13, 6:30AM CDT
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that the United States Food and Drug Administration (FDA) informed the Company that it can proceed with a multiple-dose Phase 2b clinical study of ARC-520, its clinical candidate for the treatment of chronic hepatitis B infection, under an investigational new drug (IND) application previously filed with the FDA.
ARWR: 6.88 (+0.14)

Has the Biotech Bubble Already Popped?
George Budwell, The Motley Fool - Motley Fool - Sat Apr 04, 8:59AM CDT
During the last couple of years, it seemed that you could pick almost any biotech stock and end up making jaw-dropping gains. The Nasdaq Biotech Index , for instance, has nearly tripled in value since 2010: This parabolic rise has generated...
DVAX: 23.41 (-0.07), INO: 10.39 (-0.09), BIIB: 423.57 (+1.46), GILD: 104.18 (-1.02), ARWR: 6.88 (+0.14), SRPT: 13.52 (+0.04), IBB: 363.84 (-0.66), CLDN: 13.59 (-2.77), CELG: 115.54 (+0.72)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CSMI Keeps Command Vehicles Ready for DHS Ops

CSMI Secures Critical DHS FPS Contract There's something gritty when a small outfit like CSMI lands a deal that keeps rolling the gears of national security machinery. CSMI, LLC, headquartered in Salem, New Hampshire, has snagged a recompete contract to provide Operations and Maintenance support for the Department of Homeland Security's (DHS) Federal Protective Service...

Sivers Semiconductors Shakes Up Auditors and Incentives

Rethinking the Auditing Game Well, what do you know? Sivers Semiconductors just gave the boot to Deloitte AB. Looks like they're rolling out the welcome mat for Ernst & Young AB to scrutinize their books instead. The move, coming hot from the Extraordinary General Meeting, shows they're not messing around with their financial oversight. Maybe it's a bid for fresh...

When Families Should Consider Life Insurance Plans

Let’s talk about why life insurance isn’t just for those walking around with gray hair. K.D. the Insurance Queen from Centennial, Colorado, dishes out the clearest advice on when and why families ought to have it in their arsenal. A New Mindset on Life Insurance Some folks out there think life insurance is something you ponder in your twilight years. But here’s the...

Rentvine Unleashes AI Innovations in Property Management

Rentvine's Leap in AI Technology Right off the bat, let's give these guys some due credit. Rentvine, located in Bonita Springs, is tearing through the property management software scene like a train on rocket fuel. They just rolled out a suite of AI tools that's shaking up the single-family rentals management industry. During NARPM National in Las Vegas, they showcased...

ThreatLocker Launches Global AI Awareness Campaign

Kicking Off with Pop Culture Pizzazz Ah, the sweet sound of a campaign that knows how to tug at the heartstrings of nostalgia. ThreatLocker has gotten creative with its latest strategy to get people buzzing about AI safety. They're unleashing a worldwide campaign themed around 'Terminator 2.' Now that's a throwback! If you've ever caught yourself wide-eyed at the edge of...

TruGolf's E6 Golf Platform Hits 15,000 Courses Milestone

E6's Expanding Universe of Courses TruGolf's E6 is swinging big with a library that's breaking records—more than 15,000 real-world golf courses now available on demand. It's a leap of 50% in under a year, an impressive stride for any tech-driven platform, golfing or otherwise. The magic behind this growth? On-demand generation, allowing the software's library to expand...

Rising Rates and War in Iran Hit Investor Nerves

An Unsettling Mix for Real Estate Investors The latest RCN Capital Investor Sentiment Survey reveals a shaky real estate landscape, plagued by a mix of geopolitical conflict and central bank policy changes. You know you're in trouble when investor sentiment just crawls back from an all-time low, bouncing barely from an index score of 84 to 89. It's the kind of timid...

QFIN Investors Eye Class Action Amid Regulatory Struggles

QFIN Shareholders Unite Amid Regulatory Storm It's not every day you see a stock nosedive by nearly 19% overnight. But when you're investing in a company like Qfin Holdings, you get ready for a wild ride, especially when regulatory changes from China come into play. That's exactly what's happening right now as investors rally around a class action lawsuit against Qfin....

Qingdao's Food Trade Triumph at SIAL Paris Booms

Qingdao Impresses in the Global Food Arena Well, 2026 is serving up something special from Qingdao. During SIAL Paris, everyone's talking about how Qingdao’s food companies smashed expectations with 82 million yuan in intended orders. You’ve got CCPIT Qingdao pulling the strings, setting up an exhibition platform that was nothing short of top-tier. Staging a Show at...

Lyric Health's Grace: Transforming Virtual Healthcare

Grace in the Spotlight: A Game-Changer in Virtual Healthcare If you're tired of healthcare tech making big promises and delivering little, this might pique your interest. Lyric Health has rolled out Grace, a multimodal AI addition to their Virtual Care Operating System. This isn’t your run-of-the-mill chatbot — it’s a blend of proactive health monitoring,...